Nadine Kabbani - Publications

Affiliations: 
George Mason University, Washington, DC 
Website:
http://krasnow1.gmu.edu/kabbani/

49 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Sinclair P, Kabbani N. Ionotropic and metabotropic responses by alpha 7 nicotinic acetylcholine receptors. Pharmacological Research. 197: 106975. PMID 38032294 DOI: 10.1016/j.phrs.2023.106975  0.809
2023 Nusir A, Sinclair P, Kabbani N. Mitochondrial Proteomes in Neural Cells: A Systematic Review. Biomolecules. 13. PMID 38002320 DOI: 10.3390/biom13111638  0.704
2023 Sinclair P, Hakeem J, Kumar SG, Loser D, Dixit K, Leist M, Kraushaar U, Kabbani N. Proteomic responses in the human dopaminergic LUHMES cell line to imidacloprid and its metabolites imidacloprid-olefin and desnitro-imidacloprid. Pesticide Biochemistry and Physiology. 194: 105473. PMID 37532312 DOI: 10.1016/j.pestbp.2023.105473  0.805
2023 Oz M, King JR, Yang KS, Khushaish S, Tchugunova Y, Khajah MA, Luqmani YA, Kabbani N. α7 nicotinic acetylcholine receptor interaction with G proteins in breast cancer cell proliferation, motility, and calcium signaling. Plos One. 18: e0289098. PMID 37490473 DOI: 10.1371/journal.pone.0289098  0.673
2023 Graur A, Sinclair P, Schneeweis AK, Pak DT, Kabbani N. The human acetylcholinesterase C-terminal T30 peptide activates neuronal growth through alpha 7 nicotinic acetylcholine receptors and the mTOR pathway. Scientific Reports. 13: 11434. PMID 37454238 DOI: 10.1038/s41598-023-38637-1  0.79
2022 Sinclair P, Kabbani N. Nicotinic receptor components of amyloid beta 42 proteome regulation in human neural cells. Plos One. 17: e0270479. PMID 35960729 DOI: 10.1371/journal.pone.0270479  0.795
2021 Sinclair P, Baranova A, Kabbani N. Mitochondrial Disruption by Amyloid Beta 42 Identified by Proteomics and Pathway Mapping. Cells. 10. PMID 34572029 DOI: 10.3390/cells10092380  0.769
2020 Kabbani N, Olds JL. . Molecular Pharmacology. PMID 32238438 DOI: 10.1124/Molpharm.120.000014  0.308
2018 King JR, Kabbani N. Alpha 7 nicotinic receptors attenuate neurite development through calcium activation of calpain at the growth cone. Plos One. 13: e0197247. PMID 29768467 DOI: 10.1371/Journal.Pone.0197247  0.702
2018 King JR, Ullah A, Bak E, Jafri S, Kabbani N. Ionotropic and metabotropic mechanisms of allosteric modulation of α7 nicotinic receptor intracellular calcium. Molecular Pharmacology. PMID 29588343 DOI: 10.1124/Mol.117.111401  0.704
2018 Kabbani N, Nichols RA. Beyond the Channel: Metabotropic Signaling by Nicotinic Receptors. Trends in Pharmacological Sciences. PMID 29428175 DOI: 10.1016/J.Tips.2018.01.002  0.417
2018 Nebrisi EE, Al Kury LT, Yang KS, Jayaprakash P, Howarth FC, Kabbani N, Oz M. Curcumin potentiates the function of human α7-nicotinic acetylcholine receptors expressed in SH-EP1 cells. Neurochemistry International. PMID 29341902 DOI: 10.1016/J.Neuint.2017.12.010  0.378
2017 King JR, Gillevet TC, Kabbani N. A G protein-coupled α7 nicotinic receptor regulates signaling and TNF-α release in microglia. Febs Open Bio. 7: 1350-1361. PMID 28904864 DOI: 10.1002/2211-5463.12270  0.682
2017 Bak E, Jedrzejewska-Szmek J, King J, Blackwell K, Kabbani N. Regulation of Axon Growth by Alpha 7 Nicotinic Receptor Calcium Transients at the Growth Cone Biophysical Journal. 112: 539a. DOI: 10.1016/J.Bpj.2016.11.2912  0.351
2016 King JR, Kabbani N. Alpha 7 nicotinic receptor coupling to heterotrimeric G proteins modulates RhoA activation, cytoskeletal motility, and structural growth. Journal of Neurochemistry. PMID 27167578 DOI: 10.1111/Jnc.13660  0.705
2015 Alsharari SD, King JR, Nordman JC, Muldoon PP, Jackson A, Zhu AZ, Tyndale RF, Kabbani N, Damaj MI. Effects of Menthol on Nicotine Pharmacokinetic, Pharmacology and Dependence in Mice. Plos One. 10: e0137070. PMID 26355604 DOI: 10.1371/Journal.Pone.0137070  0.772
2015 Nurulain S, Prytkova T, Sultan AM, Ievglevskyi O, Lorke D, Yang KH, Petroianu G, Howarth FC, Kabbani N, Oz M. Inhibitory actions of bisabolol on α7-nicotinic acetylcholine receptors. Neuroscience. 306: 91-9. PMID 26283025 DOI: 10.1016/J.Neuroscience.2015.08.019  0.373
2015 King JR, Nordman JC, Bridges SP, Lin MK, Kabbani N. Identification and characterization of a G protein-binding cluster in α7 nicotinic acetylcholine receptors. The Journal of Biological Chemistry. PMID 26088141 DOI: 10.1074/Jbc.M115.647040  0.814
2014 Nordman JC, Kabbani N. Microtubule dynamics at the growth cone are mediated by α7 nicotinic receptor activation of a Gαq and IP3 receptor pathway. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 28: 2995-3006. PMID 24687992 DOI: 10.1096/Fj.14-251439  0.748
2014 Corgiat BA, Nordman JC, Kabbani N. Chemical crosslinkers enhance detection of receptor interactomes. Frontiers in Pharmacology. 4: 171. PMID 24432003 DOI: 10.3389/Fphar.2013.00171  0.77
2014 Nordman JC, Phillips WS, Kodama N, Clark SG, Del Negro CA, Kabbani N. Axon targeting of the alpha 7 nicotinic receptor in developing hippocampal neurons by Gprin1 regulates growth. Journal of Neurochemistry. 129: 649-62. PMID 24350810 DOI: 10.1111/Jnc.12641  0.72
2014 Nordman JC, Muldoon P, Clark S, Damaj MI, Kabbani N. The α4 nicotinic receptor promotes CD4+ T-cell proliferation and a helper T-cell immune response. Molecular Pharmacology. 85: 50-61. PMID 24107512 DOI: 10.1124/Mol.113.088484  0.712
2013 Kabbani N, Nordman JC, Corgiat BA, Veltri DP, Shehu A, Seymour VA, Adams DJ. Are nicotinic acetylcholine receptors coupled to G proteins? Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology. 35: 1025-34. PMID 24185813 DOI: 10.1002/Bies.201300082  0.759
2013 Mahgoub M, Keun-Hang SY, Sydorenko V, Ashoor A, Kabbani N, Al Kury L, Sadek B, Howarth CF, Isaev D, Galadari S, Oz M. Effects of cannabidiol on the function of α7-nicotinic acetylcholine receptors. European Journal of Pharmacology. 720: 310-9. PMID 24140434 DOI: 10.1016/J.Ejphar.2013.10.011  0.379
2013 Ashoor A, Nordman JC, Veltri D, Yang KH, Shuba Y, Al Kury L, Sadek B, Howarth FC, Shehu A, Kabbani N, Oz M. Menthol inhibits 5-HT3 receptor-mediated currents. The Journal of Pharmacology and Experimental Therapeutics. 347: 398-409. PMID 23965380 DOI: 10.1124/Jpet.113.203976  0.701
2013 Ashoor A, Nordman JC, Veltri D, Yang KH, Al Kury L, Shuba Y, Mahgoub M, Howarth FC, Sadek B, Shehu A, Kabbani N, Oz M. Menthol binding and inhibition of α7-nicotinic acetylcholine receptors. Plos One. 8: e67674. PMID 23935840 DOI: 10.1371/Journal.Pone.0067674  0.734
2013 Kabbani N. Not so Cool? Menthol's discovered actions on the nicotinic receptor and its implications for nicotine addiction. Frontiers in Pharmacology. 4: 95. PMID 23898298 DOI: 10.3389/Fphar.2013.00095  0.329
2013 Kabbani N, Nordman JC. Capture of D2 dopamine receptor signaling complexes in striatal cells for mass spectrometry proteomic analysis. Methods in Molecular Biology (Clifton, N.J.). 964: 43-60. PMID 23296777 DOI: 10.1007/978-1-62703-251-3_4  0.764
2012 Nordman JC, Kabbani N. An interaction between α7 nicotinic receptors and a G-protein pathway complex regulates neurite growth in neural cells. Journal of Cell Science. 125: 5502-13. PMID 22956546 DOI: 10.1242/Jcs.110379  0.768
2012 Kabbani N, Woll MP, Nordman JC, Levenson R. Dopamine receptor interacting proteins: targeting neuronal calcium sensor-1/D2 dopamine receptor interaction for antipsychotic drug development. Current Drug Targets. 13: 72-9. PMID 21777187 DOI: 10.2174/138945012798868515  0.796
2011 Moreno E, Vaz SH, Cai NS, Ferrada C, Quiroz C, Barodia SK, Kabbani N, Canela EI, McCormick PJ, Lluis C, Franco R, Ribeiro JA, Sebastião AM, Ferré S. Dopamine-galanin receptor heteromers modulate cholinergic neurotransmission in the rat ventral hippocampus. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 31: 7412-23. PMID 21593325 DOI: 10.1523/Jneurosci.0191-11.2011  0.482
2009 Tecuapetla F, Koós T, Tepper JM, Kabbani N, Yeckel MF. Differential dopaminergic modulation of neostriatal synaptic connections of striatopallidal axon collaterals. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 29: 8977-90. PMID 19605635 DOI: 10.1523/Jneurosci.6145-08.2009  0.399
2009 Petko JA, Kabbani N, Frey C, Woll M, Hickey K, Craig M, Canfield VA, Levenson R. Proteomic and functional analysis of NCS-1 binding proteins reveals novel signaling pathways required for inner ear development in zebrafish. Bmc Neuroscience. 10: 27. PMID 19320994 DOI: 10.1186/1471-2202-10-27  0.781
2008 Kabbani N. Proteomics of membrane receptors and signaling. Proteomics. 8: 4146-55. PMID 18763708 DOI: 10.1002/Pmic.200800139  0.485
2008 Hannan MA, Kabbani N, Paspalas CD, Levenson R. Interaction with dopamine D2 receptor enhances expression of transient receptor potential channel 1 at the cell surface. Biochimica Et Biophysica Acta. 1778: 974-82. PMID 18261457 DOI: 10.1016/J.Bbamem.2008.01.011  0.781
2007 Kabbani N, Woll MP, Levenson R, Lindstrom JM, Changeux JP. Intracellular complexes of the beta2 subunit of the nicotinic acetylcholine receptor in brain identified by proteomics. Proceedings of the National Academy of Sciences of the United States of America. 104: 20570-5. PMID 18077321 DOI: 10.1073/Pnas.0710314104  0.659
2007 Kabbani N, Levenson R. A proteomic approach to receptor signaling: molecular mechanisms and therapeutic implications derived from discovery of the dopamine D2 receptor signalplex. European Journal of Pharmacology. 572: 83-93. PMID 17662712 DOI: 10.1016/J.Ejphar.2007.06.059  0.679
2007 Kabbani N, Changeux JP. Proteomic Profiling of Interactions Comprising the Beta 2 Subunit of the Nicotine Receptor Using MALDI‐TOF MS Analysis The Faseb Journal. 21. DOI: 10.1096/Fasebj.21.5.A421-A  0.519
2006 Kabbani N, Levenson R. Antipsychotic-induced alterations in D2 dopamine receptor interacting proteins within the cortex. Neuroreport. 17: 299-301. PMID 16462601 DOI: 10.1097/01.Wnr.0000199460.24412.04  0.67
2006 Basile M, Lin R, Kabbani N, Karpa K, Kilimann M, Simpson I, Kester M. Paralemmin interacts with D3 dopamine receptors: implications for membrane localization and cAMP signaling. Archives of Biochemistry and Biophysics. 446: 60-8. PMID 16386234 DOI: 10.1016/J.Abb.2005.10.027  0.824
2005 Blasiole B, Kabbani N, Boehmler W, Thisse B, Thisse C, Canfield V, Levenson R. Neuronal calcium sensor-1 gene ncs-1a is essential for semicircular canal formation in zebrafish inner ear. Journal of Neurobiology. 64: 285-97. PMID 15898063 DOI: 10.1002/Neu.20138  0.733
2005 Binda AV, Kabbani N, Levenson R. Regulation of dense core vesicle release from PC12 cells by interaction between the D2 dopamine receptor and calcium-dependent activator protein for secretion (CAPS). Biochemical Pharmacology. 69: 1451-61. PMID 15857609 DOI: 10.1016/J.Bcp.2005.02.015  0.802
2005 Kabbani N, Hannan MA, Levenson R. Unraveling the dopamine receptor signalplex by DRIPs and DRAPs Current Proteomics. 2: 209-223. DOI: 10.2174/157016405774641174  0.665
2004 Kabbani N, Jeromin A, Levenson R. Dynamin-2 associates with the dopamine receptor signalplex and regulates internalization of activated D2 receptors. Cellular Signalling. 16: 497-503. PMID 14709338 DOI: 10.1016/J.Cellsig.2003.09.011  0.655
2003 Koh PO, Undie AS, Kabbani N, Levenson R, Goldman-Rakic PS, Lidow MS. Up-regulation of neuronal calcium sensor-1 (NCS-1) in the prefrontal cortex of schizophrenic and bipolar patients. Proceedings of the National Academy of Sciences of the United States of America. 100: 313-7. PMID 12496348 DOI: 10.1073/Pnas.232693499  0.691
2002 Kabbani N, Negyessy L, Lin R, Goldman-Rakic P, Levenson R. Interaction with neuronal calcium sensor NCS-1 mediates desensitization of the D2 dopamine receptor. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 22: 8476-86. PMID 12351722 DOI: 10.1523/Jneurosci.22-19-08476.2002  0.831
2002 Binda AV, Kabbani N, Lin R, Levenson R. D2 and D3 dopamine receptor cell surface localization mediated by interaction with protein 4.1N. Molecular Pharmacology. 62: 507-13. PMID 12181426 DOI: 10.1124/Mol.62.3.507  0.779
2001 Lin R, Karpa K, Kabbani N, Goldman-Rakic P, Levenson R. Dopamine D2 and D3 receptors are linked to the actin cytoskeleton via interaction with filamin A. Proceedings of the National Academy of Sciences of the United States of America. 98: 5258-63. PMID 11320256 DOI: 10.1073/Pnas.011538198  0.808
2000 Karpa KD, Lin R, Kabbani N, Levenson R. The dopamine D3 receptor interacts with itself and the truncated D3 splice variant d3nf: D3-D3nf interaction causes mislocalization of D3 receptors. Molecular Pharmacology. 58: 677-83. PMID 10999936 DOI: 10.1124/Mol.58.4.677  0.805
Show low-probability matches.